The ACMD has been busy: correspondence to government includes Ganaxolone: ACMD advice, Zuranolone: ACMD advice and Somapacitan, lonapegsomatropin and somatrogon: ACMD advice. Its Open call for evidence – Ketamine harms assessment will close on 19 August.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
